Suzanne Blaising, PhD is the psychedelic lead at the Wholeness Center in Fort Collins, Colorado.

She is a dedicated and compassionate therapist who understands that life’s challenges often require us to adapt and grow. With over 25 years of experience, she specializes in helping adults navigate through depression, anxiety, grief, self-esteem, and relationship issues, providing a safe environment that fosters healing and growth.

Through her work, Dr. Blaising encourages clients to cultivate self-care by becoming keen observers of themselves and their surroundings, asking hard questions, and exploring new possibilities with compassion.

Her expertise spans various therapeutic modalities, including ketamine-assisted psychotherapy and psychedelic integration and facilitation. Dr. Blaising served as a sub-investigator on the MAPS Phase 3 clinical trials for MDMA-assisted psychotherapy for PTSD and completed the MAPS therapist training program in 2022. She contributed to MindMeds Phase 2 LSD clinical trials for the treatment of generalized anxiety disorder as a dosing session monitor and is currently a lead therapist in Beckley’s 5-MeO-DMT Clinical Trial.

Dr. Blaising’s academic journey includes a PhD from the Institute for Clinical Social Work in Chicago, and a Master of Social Work (MSW) from the University of Illinois – Chicago.

She holds certifications in Eye Movement Desensitization and Reprocessing (EMDR); Ketamine and Psychedelic Medicine Training from PRATI; Divorce Mediation & Conflict Resolution from Northwestern University; Relationship Enhancement Educator from the National Institute for Relationship Enhancement; Recovery from Affairs Recommended Therapist from Beyond Affairs Network (BAN); Certified Smart Steps Educator from the Stepfamily Association of America, and Certified Premarital Educator from the Pick A Partner Program.

Active in her professional community, Dr. Blaising is a member of the Eye Movement Desensitization and Reprocessing International Association (EMDRIA), American Psychological Association (APA), and the National Association of Social Workers (NASW). She served on the therapist advisory committee for the American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3),